Anatomic Pathology Market 2024 – Market Size & Segments Analysis, Industry Trends, Manufacturers Analysis, Opportunities and Forecast 2030

The anatomic pathology market was valued at $36.9 billion in 2022, and a CAGR of 7.2% is expected during the forecast period. The increasing number of patients with chronic diseases like cancer and others is driving growth in the market significantly. It refers to the branch of pathology that deals with the diagnosis of disease based on the examination of the organs, tissues, and the whole body. Increasing demand for anatomical pathologies for identifying cancer is driving growth in the market significantly.

Advances in technology, the increasing prevalence of chronic diseases, the growing geriatric population, and the demand for personalized medicine are driving significant growth in the market. Major players in this market include laboratories, diagnostic companies, and healthcare providers focused on improving diagnostic accuracy and patient outcomes.

Growth Drivers

Innovations such as digital pathology, automation of workflows, and molecular diagnostics have significantly enhanced the efficiency and accuracy of pathological analysis. The rising incidence of cancer, cardiovascular diseases, and other chronic illnesses requires biopsy and other big examinations of tissues. The demographic trend towards an aging population correlates with higher incidence rates of diseases that require pathology services for diagnosis. Improvements in healthcare infrastructure in emerging economies are expanding access to diagnostic services, including anatomic pathology, thereby improving market growth.

Increasing awareness among both healthcare providers and patients about the importance of early and accurate disease diagnosis is contributing to the growth of the anatomic pathology market. Collaboration between pathology laboratories, academic institutions, and healthcare providers is fostering innovation and expanding service offerings, further fueling market growth. Favorable regulatory policies and initiatives aimed at improving healthcare standards and patient outcomes are supporting market growth by encouraging the adoption of advanced diagnostic techniques. Improvement in healthcare infrastructure in almost every country in the entire world is the key reason behind significant growth in the market.

 Segmentation

By Products and Services

Services

·         Histopathology

·         Cytopathology

Consumables

·         Antibodies

o   Primary

o   Secondary

·         Kits and Reagents

o   Stains and Solvents

o   Fixatives

o   Other Kits and Reagents

·         Probes

·         Other Consumables

Instruments

·         Slide Staining Systems

·         Tissues Processing Systems

·         Cell Processors

·         Microtomes

·         Embedding Systems

·         CoverSlippers

·         Other Instruments

By End-User

·         Hospital Laboratories

·         Clinical Laboratories

·         Other End-Users

Regional Outlook

·         Asia Pacific

·         North America

·         Latin America

·         Middle East and Africa

·         Europe

Anatomical Pathology Market by Type Segmentation

On the basis of type, the anatomical pathology market is segmented into histopathology and cytopathology. Histopathology is the leading segment in the anatomical pathology market because it plays a crucial role in diagnosing disease by examining tissue samples under a microscope. It provides essential information about the nature and extent of disease, guiding treatment decisions. It is widely used across various medical specialties such as oncology, gastroenterology, dermatology, and others.

Histopathology helps diagnose cancer, inflammatory diseases, infections, and genetic disorders. It is crucial to understand disease mechanisms by doing clinical research. With an aging population and an increasing prevalence of chronic diseases like cancer, there is a growing demand for accurate diagnostic services.

Anatomical Pathology Market by End-User Segmentation

On the basis of the end-user, the anatomical pathology market is segmented into hospital laboratories, clinical laboratories, and other end-users. Hospital laboratories are the leading segment among end users. This is primarily because hospitals have a wide range of clinical specialties and patient populations and require extensive pathological services for diagnosis, treatment planning, and monitoring.

Hospital laboratories are equipped to handle a variety of tests and procedures, making them key players in the anatomical pathology sector. Clinical laboratories are also not far behind due to some big names in this field. Some brands are available as diagnostic centers outside of the hospital premises and are serving patients with all of their capabilities and potential. The increasing number of cancer patients all over the world due to hectic lifestyles is driving growth in the market.

Regional Outlook

On the basis of the regions, the anatomical pathology market is segmented into 5 parts: Asia Pacific, North America, Latin America, Europe, and the Middle East and Africa. North America is the leading segment and is expected to grow during the forecast period due to technological advancement and increasing awareness about chronic diseases like cancer. The increasing number of research institutes in the region is driving growth in the market significantly. Increasing healthcare expenditure and the disposable income of people in the region are the key factors behind the significant growth in the region. Danaher Corporation in the United States held the second position in the market.

Asia Pacific is the second-leading region in the market due to increasing disposable income, healthcare infrastructure, and the increasing number of cancer patients in the region, which is driving growth in the market. Emerging economies like China and India are witnessing a significant number of cancer patients and, thus, a greater number of anatomic pathologies in the region. Rapid economic growth in these countries is the key factor behind the significant growth in the market. Asia-Pacific countries are increasingly adopting advanced healthcare technologies and diagnostic tools. It includes digital pathology, which enhances the accuracy of anatomic pathology services. Rising awareness and education among healthcare providers and patients is driving significant growth in the market.

Countries like India, Singapore, and Thailand are major hubs for medical tourism. High-quality pathology services attract international patients to these countries. European countries like England, Russia, Spain, and Germany are witnessing significant growth during the forecast period in the anatomic pathology market. Increasing awareness among the people about the treatment of chronic diseases is driving significant growth in the market.

The increasing number of aging people, and thus the increasing number of cancer patients, are driving growth in the market. Middle East and Africa, as well as Latin America, are also experiencing moderate growth in the market due to increasing healthcare expenditure in countries like South Africa, Brazil, Argentina, Egypt, and Saudi Arabia. The presence of key players in regions like Europe and North America is the key factor behind the growth of the market.

Key Players

·         F.Hoffman-La Roche Limited

·         Danaher Corporation

·         PHC Holdings Corporation

·         Quest Diagnostic Incorporation

·         Agilent Technologies Inc.

·         Cardinal Health

·         NeoGenomics Laboratories Inc

·         Thermo Fisher Scientific Inc

·         Sakura Finetek USA Inc.

·         Laboratory Corporation of America Holdings

·         Other Players